One step closer to alleviating uraemic pruritus
- PMID: 31988499
- DOI: 10.1038/s41581-020-0251-3
One step closer to alleviating uraemic pruritus
Comment on
-
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.N Engl J Med. 2020 Jan 16;382(3):222-232. doi: 10.1056/NEJMoa1912770. Epub 2019 Nov 8. N Engl J Med. 2020. PMID: 31702883 Clinical Trial.
References
-
- Weiss, M. et al. Prevalence of chronic itch and associated factors in haemodialysis patients: a representative cross-sectional study. Acta Derm. Venereol. 95, 816–821 (2015). - DOI
-
- Fishbane, S. et al. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N. Engl. J. Med. 382, 222–232 (2019). - DOI
-
- Reich, A. et al. Itch assessment with visual analogue scale and numerical rating scale: determination of minimal clinically important difference in chronic itch. Acta Derm. Venereol. 96, 978–980 (2016). - DOI
-
- Plewig, N. et al. The course of chronic itch in hemodialysis patients: results of a 4-year follow-up study of GEHIS (German Epidemiological Hemodialysis Itch Study). J. Eur. Acad. Derm. Venereol. 33, 1429–1435 (2019). - DOI
-
- Riepe, C. et al. Minimal clinically important difference in chronic pruritus appears to be dependent on baseline itch severity. Acta Derm. Venereol. 99, 1288–1290 (2019). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical